内分泌免疫相关不良事件：一把双刃剑？ - Suppr | 超能文献

文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Endocrine immune-related adverse events: a double-edged sword?内分泌免疫相关不良事件：一把双刃剑？

Transl Lung Cancer Res. 2021 Jan;10(1):13-17. doi: 10.21037/tlcr-2020-16.

2

Realistic assessment of drug-induced adverse events: a double-edged sword.

Am J Med. 2010 Nov;123(11):971. doi: 10.1016/j.amjmed.2010.07.012.

3

The Double-Edged Sword Effect of Relational Crafting on Job Well-Being.关系构建对工作幸福感的双刃剑效应

Front Psychol. 2022 Feb 16;13:713737. doi: 10.3389/fpsyg.2022.713737. eCollection 2022.

4

Topical calcineurin inhibitors as a double-edged sword in rosacea: A systematic review.局部钙调磷酸酶抑制剂在酒渣鼻中的双刃剑作用：系统评价。

J Cosmet Dermatol. 2022 Apr;21(4):1695-1704. doi: 10.1111/jocd.14315. Epub 2021 Jul 10.

5

Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander".癌症治疗中的免疫检查点阻断：双刃剑交叉靶向宿主作为“无辜的旁观者”。

Toxins (Basel). 2014 Mar 3;6(3):914-33. doi: 10.3390/toxins6030914.

6

14-3-3sigma, the double-edged sword of human cancers.14-3-3西格玛，人类癌症的双刃剑。

Am J Transl Res. 2009 Jun 8;1(4):326-40.

7

Lewis Base Plays a Double-Edged-Sword Role in Trap State Engineering of Perovskite Polycrystals.路易斯碱在钙钛矿多晶体陷阱态工程中扮演双刃剑角色。

J Phys Chem Lett. 2022 Feb 17;13(6):1571-1577. doi: 10.1021/acs.jpclett.2c00167. Epub 2022 Feb 9.

8

[Medicine--the double-edged sword].[医学——双刃剑]

Ugeskr Laeger. 2015 May 11;177(20).

9

Off-label Medication Use: A Double-edged Sword.非适应证用药：一把双刃剑。

Indian J Crit Care Med. 2021 Aug;25(8):845-846. doi: 10.5005/jp-journals-10071-23951.

10

Breaking the double-edged sword of effort/trying hard: Developmental equilibrium and longitudinal relations among effort, achievement, and academic self-concept.打破努力/拼命努力这把双刃剑：努力、成就和学业自我概念之间的发展平衡及纵向关系。

Dev Psychol. 2016 Aug;52(8):1273-90. doi: 10.1037/dev0000146.

引用本文的文献

1

PD-1-induced encephalopathy: a report of 2 cases on neurological toxicities with immune checkpoint inhibitors.程序性死亡受体 1（PD-1）诱导的脑病：2例免疫检查点抑制剂所致神经毒性报告

Transl Cancer Res. 2024 Feb 29;13(2):1196-1207. doi: 10.21037/tcr-23-2043. Epub 2024 Feb 2.

2

Predictive Biomarkers of Severe Immune-Related Adverse Events With Immune Checkpoint Inhibitors: Prevention, Underlying Causes, Intensity, and Consequences.免疫检查点抑制剂所致严重免疫相关不良事件的预测生物标志物：预防、潜在原因、强度及后果

Front Med (Lausanne). 2022 Jun 14;9:908752. doi: 10.3389/fmed.2022.908752. eCollection 2022.

本文引用的文献

1

Thyroid Toxicity Following Immune Checkpoint Inhibitor Treatment in Advanced Cancer.晚期癌症患者接受免疫检查点抑制剂治疗后的甲状腺毒性。

Thyroid. 2020 Oct;30(10):1458-1469. doi: 10.1089/thy.2020.0032. Epub 2020 May 8.

2

PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer Patients.PD-L1 抑制剂诱导的甲状腺炎与癌症患者的总体生存改善相关。

Thyroid. 2020 Feb;30(2):177-184. doi: 10.1089/thy.2019.0250. Epub 2020 Jan 9.

3

Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis.

尼伏鲁单抗和派姆单抗相关的垂体内分泌炎是一种与伊匹单抗相关的垂体内分泌炎不同的临床实体。

Eur J Endocrinol. 2019 Sep;181(3):211-219. doi: 10.1530/EJE-19-0238.

4

Pembrolizumab-Induced Thyroiditis.帕博利珠单抗相关性甲状腺炎。

Endocr Pathol. 2019 Jun;30(2):163-167. doi: 10.1007/s12022-019-9579-2.

5

Histology of Nivolumab-Induced Thyroiditis.纳武利尤单抗诱发的甲状腺炎的组织学

Thyroid. 2018 Dec;28(12):1727-1728. doi: 10.1089/thy.2018.0418. Epub 2018 Nov 15.

6

Increased Reporting of Immune Checkpoint Inhibitor-Associated Diabetes.免疫检查点抑制剂相关糖尿病报告增加。

Diabetes Care. 2018 Dec;41(12):e150-e151. doi: 10.2337/dc18-1465. Epub 2018 Oct 10.

7

Immune-Related Thyroiditis with Immune Checkpoint Inhibitors.免疫检查点抑制剂相关甲状腺炎。

Thyroid. 2018 Oct;28(10):1243-1251. doi: 10.1089/thy.2018.0116.

8

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.与免疫检查点阻断相关的免疫相关不良事件。

N Engl J Med. 2018 Jan 11;378(2):158-168. doi: 10.1056/NEJMra1703481.

9

Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small-Cell Lung Cancer.免疫相关不良反应与纳武利尤单抗治疗非小细胞肺癌疗效的相关性。

JAMA Oncol. 2018 Mar 1;4(3):374-378. doi: 10.1001/jamaoncol.2017.2925.

10

Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.不同免疫检查点抑制剂方案应用后内分泌功能障碍的发生率：系统评价和荟萃分析。

JAMA Oncol. 2018 Feb 1;4(2):173-182. doi: 10.1001/jamaoncol.2017.3064.

内分泌免疫相关不良事件：一把双刃剑？ - Suppr | 超能文献

Endocrine immune-related adverse events: a double-edged sword?

作者信息

Rengarajan Michelle, Gainor Justin F

机构信息

Division of Endocrinology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

出版信息

Transl Lung Cancer Res. 2021 Jan;10(1):13-17. doi: 10.21037/tlcr-2020-16.

DOI:10.21037/tlcr-2020-16

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7867773/

Abstract

摘要